Drreddys Laboratories | RDY - L'Utile Operativo





L'Utile Operativo Cambiamento Data
ANI Pharmaceuticals USD 38.71M 9.58M 2026-03
Aurora Cannabis CAD -10.03M 25.76M 2026-03
Bayer EUR 3.53B 2.42B 2026-03
Canopy Growth CAD -27.47M 14.81M 2026-03
Cipla INR 8.88B 2.74B 2026-06
Corcept Therapeutics USD 41.3M 90.9M 2026-06
Drreddys Laboratories INR 829M 13.5B 2026-03
GlaxoSmithKline GBP 2.6B 312M 2026-06
Hikma Pharmaceutical USD 348M 161M 2025-12
Lonza CHF 673M 243M 2025-06
Novartis USD 4.75B 515M 2026-06
Pacira USD 4.62M 1.43M 2026-03
Phibro Animal Health USD 54.99M 2.36M 2025-12
Prestige Brands USD 75.49M 7M 2026-03
Richter Gedeon HUF 62.32B 1.26B 2026-03
Sun Pharmaceuticals INR 35.57B 8.05B 2026-06
Supernus Pharmaceuticals USD -35.25M 49.07M 2026-03
Teva Pharmaceutical Industries USD 235M 523M 2026-06